Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Trends, charts, and maps, https://clinicaltrials.gov/ct2/resources/trends (2015, accessed 7 November 2015).

Dialogues in diversifying clinical trials, http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/WomensHealthResearch/UCM334959.pdf (2011, accessed 7 November 2015).

Burke

. Rethinking the therapeutic misconception: social justice, patient advocacy, and cancer clinical trial recruitment in the US safety net. BMC Med Ethics 2014; 15: 68–68.

NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research, http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm (2001, accessed 18 June 2015).

Murthy

Krumholz

Gross

. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004; 291: 2720–2726.

Epstein

. The rise of ‘recruitmentology’ clinical research, racial knowledge, and the politics of inclusion and difference. Soc Stud Sci 2008; 38: 801–832.

Unger

Hershman

Albain

. Patient income level and cancer clinical trial participation. J Clin Oncol 2013; 31: 536–542.

Jimenez

Zhang

Joffe

. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment? J Palliat Med 2013; 16: 256–262.

Affordable Care Act Implementation, https://www.cms.gov/CCIIO/Resources/Fact-Sheets-and-FAQs/aca_implementation_faqs15.html (2015, accessed 9 July 2015).

The problem of representativeness of clinical trial participants: understanding the role of hidden costs

Abstract

Get full access to this article

References